Canopy Growth (TSX:WEED) published a response regarding a possible class action suit that has named newly-acquired Mettrum Health.
As quoted in the press release:
Details of a possible class action suit naming Mettrum Health Corp., an entity that was fully acquired by Canopy Growth Corporation (“Canopy Growth” or “the Company”) (TSX: WEED) on January 31, 2017 have been publicly reported.
In response to these reports, the Company wishes to state that it conducted thorough due diligence during the process of acquiring Mettrum Health Corp. and was aware of the extent and scope of the recall Mettrum was conducting.
Canopy Growth was, and continues to be satisfied with Health Canada’s independent decision to classify the Mettrum recall as a Type III recall, defined as “a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.”
The Company will defend itself vigorously against all suits relating to Mettrum recalls.